Centro de Investigación Biomédica en Red de Cáncer-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancer

    Genes and Immunity, Vol. 25, Núm. 5, pp. 437-439

2018

  1. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

    Journal of Clinical Investigation, Vol. 128, Núm. 9, pp. 3887-3905